Skip to main content

US ClosedU.S. Closed

ZBIO: Zenas BioPharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments.

52W Range

57thpctl

Volume

0.58×avg

Market Cap

1.97BUSD

P/E Ratio

-3.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Zenas BioPharma, Inc.

ZBIONASDAQ Global Select·USD·Closed

Zenas BioPharma, Inc.

ZBIONASDAQ·USD·Closed

$31.27

−4.14%

$31.27

−$1.35 (4.14%)

52W Range

57thpctl

Volume

0.58×avg

Mkt Cap

1.97BUSD

P/E

-3.3TTM

Div Yield

–ann